The effect of immobilization of heparin and bone morphogenic protein-2 to bovine bone substitute on osteoblast-like cell’s function
1
조회
0
다운로드
2
인용
0
참고문헌
초록
PURPOSE. This study was performed to investigate the ability of recombinant human-bone morphogenic protein-2 immobilized on a heparin-grafted bone substrate to enhance the osteoblastic functions. MATERIALS AND METHODS. The Bio-Oss(R)., not coated with any material, was used as a control group. In rhBMP-2-Bio-Oss(R). group, rhBMP-2 was coated with Bio-Oss(R). using only deep and dry methods (50 ng/mL, 24 h). In heparinized rhBMP-2-Bio-Oss(R). group, dopamine was anchored to the surface of Bio-Oss(R)., and coated with heparin. rhBMP- 2 was immobilized onto the heparinized- Bio-Oss(R). surface. The release kinetics of the rhBMP-2-Bio-Oss(R). and heparinized rhBMP-2-Bio-Oss(R). were analyzed using an enzyme-linked immunosorbent assay. The biological activities of the MG63 cells on the three groups were investigated via cytotoxicity assay, cell proliferation assay, alkaline phosphatase (ALP) measurement, and calcium deposition determination. Statistical comparisons were carried out by one-way ANOVA test. Differences were considered statistically significant at *P<.05 and **P<.001. RESULTS. The heparinized rhBMP-2-Bio-Oss(R). showed more sustained release compared to the rhBMP-2-Bio-Oss(R). over an extended time. In the measurement of the ALP activity, the heparinized group showed a significantly higher ALP activity when compared with the non-heparinized groups (P<.05). The MG63 cells cultivated in the group with rhBMP-2 showed increased calcium deposition, and the MG63 cells from the heparinized group increased more than those that were cultivated in the non-heparinized groups. CONCLUSION. Heparin increased the rhBMP-2 release amount and made sustained release possible, and heparinized Bio-Oss(R). with rhBMP-2 successfully improved the osteoblastic functions.
Abstract
PURPOSE. This study was performed to investigate the ability of recombinant human-bone morphogenic protein-2 immobilized on a heparin-grafted bone substrate to enhance the osteoblastic functions. MATERIALS AND METHODS. The Bio-Oss(R)., not coated with any material, was used as a control group. In rhBMP-2-Bio-Oss(R). group, rhBMP-2 was coated with Bio-Oss(R). using only deep and dry methods (50 ng/mL, 24 h). In heparinized rhBMP-2-Bio-Oss(R). group, dopamine was anchored to the surface of Bio-Oss(R)., and coated with heparin. rhBMP- 2 was immobilized onto the heparinized- Bio-Oss(R). surface. The release kinetics of the rhBMP-2-Bio-Oss(R). and heparinized rhBMP-2-Bio-Oss(R). were analyzed using an enzyme-linked immunosorbent assay. The biological activities of the MG63 cells on the three groups were investigated via cytotoxicity assay, cell proliferation assay, alkaline phosphatase (ALP) measurement, and calcium deposition determination. Statistical comparisons were carried out by one-way ANOVA test. Differences were considered statistically significant at *P<.05 and **P<.001. RESULTS. The heparinized rhBMP-2-Bio-Oss(R). showed more sustained release compared to the rhBMP-2-Bio-Oss(R). over an extended time. In the measurement of the ALP activity, the heparinized group showed a significantly higher ALP activity when compared with the non-heparinized groups (P<.05). The MG63 cells cultivated in the group with rhBMP-2 showed increased calcium deposition, and the MG63 cells from the heparinized group increased more than those that were cultivated in the non-heparinized groups. CONCLUSION. Heparin increased the rhBMP-2 release amount and made sustained release possible, and heparinized Bio-Oss(R). with rhBMP-2 successfully improved the osteoblastic functions.
참고문헌 (41)
- Amerio P, "The effect of deproteinized bovine bone on osteoblast growth factors and proinflammatory cytokine production", Clin Oral Implants Res, 32, pp.650~655 (2010)
- Del Fabbro M, "Implant survival rates after maxillary sinus augmentation", Eur J Oral Sci, 116, pp.497~506 (2008)
- Mangano C, "Maxillary sinus augmentation using an engineered porous hydroxyapatite: a clinical, histological, and transmission electron microscopy study in man", J Oral Implantol, 32, pp.122~131 (2006)
- Esposito M, "Interventions for replacing missing teeth: bone augmentation techniques for dental implant treatment", Cochrane Database Syst Rev 2008;3:CD003607, ~ (2008)
- Fulmer NL, "Anorganic bovine bone and analogs of bone mineral as implants for craniofacial surgery: a literature review", J Long Term Eff Med Implants, 8, pp.69~78 (1998)
- Ku¨bler A, "Growth and proliferation of human osteoblasts on different bone graft substitutes: an in vitro study", Implant Dent, 13, pp.171~179 (2004)
- Turhani D, "In vitro study of adherent mandibular osteoblast-like cells on carrier materials", Int J Oral Maxillofac Surg, 34, pp.543~550 (2005)
- Reddi AH, "Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage", J Cell Biochem, 56, pp.192~195 (1994)
- Reddi AH, "Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Maureen Owen revisited", Clin Orthop Relat Res, 313, pp.115~119 (1995)
- Duneas N, "Transforming growth factorbeta 1: induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with osteogenic protein-1 (BMP-7)", Growth Factors, 15, pp.259~277 (1998)
- Hall J, "Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model", J Clin Periodontol, 34, pp.444~451 (2007)
- Chen D, "Bone morphogenetic proteins", Growth Factors, 22, pp.233~241 (2004)
- Bessa PC, "Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release", J Tissue Eng Regen Med, 4, pp.349~355 (2010)
- Sykaras N, "Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: a biomechanics study", Clin Oral Investig, 8, pp.196~205 (2004)
- Sellers RS, "Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2)", J Bone Joint Surg Am, 82, pp.151~160 (2000)
- Bax BE, "Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia", Calcif Tissue Int, 65, pp.83~89 (1999)
- Sheehan JP, "Molecular methods of enhancing lumbar spine fusion", Neurosurgery, 39, pp.548~554 (1996)
- King GN, "Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects", J Dent Res, 76, pp.1460~1470 (1997)
- Sellers RS, "The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage", J Bone Joint Surg Am, 79, pp.1451~1463 (1997)
- Zellin G, "Importance of delivery systems for growthstimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects", J Biomed Mater Res, 35, pp.181~190 (1997)
- Kim J, "Characterization of low-molecular-weight hyaluronic acid-based hydrogel and differential stem cell responses in the hydrogel microenvironments", J Biomed Mater Res A, 88, pp.967~975 (2009)
- Kim J, "Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells", BIOMATERIALS, 28, pp.1830~1837, ELSEVIER SCI LTD
- Lee TC, "Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment", Neurosurgery, 58, pp.373~380 (2006)
- Jeon O, "Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery", Biochem Biophys Res Commun, 369, pp.774~780 (2008)
- Sasisekharan R, "On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans", Angiogenesis, 1, pp.45~54 (1997)
- Perets A, "Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres", J Biomed Mater Res A, 65, pp.489~497 (2003)
- Ishibe T, "Bone formation on apatite-coated titanium with incorporated BMP-2", heparin in vivo, 2009, pp.108, 867~875
- von Walter M, "Biomimetic modification of the TiO(2)", glass composite Ecopore with heparinized collagen and the osteoinductive factor BMP-2, 2008, pp.4, 997~1004
- Kodama T, "Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin", Int J Oral Maxillofac Implants, 23, pp.1013~1019 (2008)
- Ishibe T, "Bone formation on apatite-coated titanium with incorporated BMP-2", heparin in vivo, 2009, pp.108, 867~875
- Kim SE, "The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function", BIOMATERIALS, 32, pp.366~373, ELSEVIER SCI LTD
- Tadjoedin ES, "Deproteinized cancellous bovine bone (Bio-Oss) as bone substitute for sinus floor elevation. A retrospective, histomorphometrical study of five cases", J Clin Periodontol, 30, pp.261~270 (2003)
- Bessho K, "Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2", Br J Oral Maxillofac Surg, 38, pp.645~649 (2000)
- Tokuhara Y, "Repair of experimentally induced large osteochondral defects in rabbit knee with various concentrations of Escherichia coli-derived recombinant human bone morphogenetic protein-2", Int Orthop, 34, pp.761~767 (2010)
- Lee JH, "The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli", BIOMATERIALS, 31, pp.3512~3519, ELSEVIER SCI LTD
- Ho YC, "Heparin-functionalized chitosan- alginate scaffolds for controlled release of growth factor", Int J Pharm, 376, pp.69~75 (2009)
- Lin H, "The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2", Biomaterials, 29, pp.1189~1197 (2008)
- Park YJ, "Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration", BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 43, pp.17~24, PORTLAND PRESS LTD
- Turksen K, "Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo", J Histochem Cytochem, 40, pp.1339~1352 (1992)
- van den Beucken JJ, "Functionalization of multilayered DNAcoatings with bone morphogenetic protein 2", J Control Release, 113, pp.63~72 (2006)
- Bancroft GN, "Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner", Proc Natl Acad Sci USA, 99, pp.12600~12605 (2002)